Japan Approves SIGA Technologies Antiviral

SIGA’s antiviral approved in Japan for orthopoxvirus treatment
The approval of TEPOXX in Japan marks another significant milestone in our mission to expand access to this critical antiviral treatme
Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox
On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment TEPOXX (tecovirimat 200 mg capsules) for smallpox, mpox, cowpox, as well as complications following smallpox vaccination in adults and pediatric patients weighing at least 13 kg.
SIGA's Tepoxx Gets Regulatory Approval In Japan For Treatment Of Orthopoxviruses
(RTTNews) - SIGA Technologies, Inc. (SIGA), Thursday announced that its tecovirimat 200 mg capsules, traded as TEPOXX, has secured regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as well as complications following smallpox vaccination in adults and pediatric patients weighing at least 13 kg.
SIGA wins Japan approval for mpox therapy Tepoxx
SIGA Technologies (NASDAQ:SIGA) announced Thursday that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approved its antiviral product Tepoxx (tecovirimat) for the treatment of orthopoxviruses,
SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses
SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses: New York Saturday, January 4, 2025, 12:00 Hrs [IST] SIGA Technologies, a commercial s
Siga Technologies approved in Japan for treatment of orthopoxviruses
Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as
TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpox Japan Biotechno Pharma Co., Ltd. engaged as exclusive distributor to supply TEPOXX to Japan’s national stockpile Comprehensive data package demonstrates strong safety profile and robust preclinical efficacy NEW YORK,
news.stocktradersdaily7d
(SIGA) Trading Advice
Trading Advice for Siga Technologies Inc. SIGA including day trading swing trading and long term investing plans for SIGA ...
Ghanaweb.com12d
Prioritise operations of SIGA to address inefficiencies in SEs – John Boadu to incoming government
John Boadu, Director General (DG) of the State Interests and Governance Authority (SIGA), has called on the incoming ...
Reuters26d
Siga's mpox drug did not improve lesion resolution or pain, NIH study finds
Dec 10 (Reuters) - Siga Technologies' (SIGA.O), opens new tab antiviral drug did not reduce the time to lesion resolution or have an effect on pain among adults affected by the clade II strain of ...
Graphic13d
SIGA unveils 'Entity Portal' to oversee SOE operations
The State Interests and Governance Authority (SIGA) has officially launched the SIGA Entity Portal, a web-based platform ...
Yahoo Finance27d
Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
NIAID reported that SIGA’s tecovirimat, a highly targeted antiviral treatment, did not demonstrate efficacy in time to skin and mucosal lesion resolution compared to placebo in patients with ...